Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
7.83B | 10.37B | 10.03B | 7.65B | 5.95B | Gross Profit |
1.77B | 2.60B | 2.50B | 2.13B | 1.47B | EBIT |
551.70M | 1.16B | 1.37B | 1.19B | 465.60M | EBITDA |
770.10M | 1.51B | 1.54B | 1.44B | 832.00M | Net Income Common Stockholders |
-213.10M | 743.40M | 863.90M | 793.90M | 363.40M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
260.80M | 491.80M | 324.90M | 339.40M | 1.40B | Total Assets |
6.29B | 6.78B | 6.46B | 5.03B | 4.89B | Total Debt |
3.13B | 2.95B | 3.02B | 2.19B | 2.65B | Net Debt |
2.95B | 2.46B | 2.81B | 1.92B | 1.32B | Total Liabilities |
6.05B | 5.96B | 5.92B | 5.16B | 5.36B | Stockholders Equity |
241.30M | 808.90M | 534.90M | -135.60M | -478.70M |
Cash Flow | Free Cash Flow | |||
313.70M | 1.07B | -9.90M | 72.30M | 674.30M | Operating Cash Flow |
740.10M | 1.66B | 649.50M | 770.00M | 954.20M | Investing Cash Flow |
-425.50M | -574.90M | -853.40M | -687.70M | -260.30M | Financing Cash Flow |
-553.10M | -629.20M | 190.30M | -1.14B | 583.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | C$1.41B | 12.27 | 15.84% | 6.59% | 7.98% | -0.29% | |
73 Outperform | C$1.08B | 9.61 | 11.27% | 6.51% | -0.27% | -15.99% | |
59 Neutral | $11.74B | 10.16 | -1.06% | 4.15% | 1.27% | -16.61% | |
48 Neutral | $3.71B | 19.66 | -3.01% | 1.71% | -23.54% | -130.34% |